Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma

Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma

The combination of Resminostat (HDACi) and Ruxolitinib (JAKi) exerted cytotoxic effects and inhibited proliferation of CTCL cell lines (MyLa, SeAx) in previously published work. A xenograft tumor formation was produced by implanting the MyLa or SeAx cells on top of the chick embryo chorioallantoic m...

Full description

Bibliographic Details
Main Authors: Fani Karagianni, Christina Piperi, Berta Casar, Dalia de la Fuente-Vivas, Rocío García-Gómez, Kyriaki Lampadaki, Vasiliki Pappa, Evangelia Papadavid
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
chicken chorioallantoic membrane
CAM
MyLa
SeAx
Resminostat
Ruxolitinib
Online Access:https://www.mdpi.com/2072-6694/14/4/1070

Internet

https://www.mdpi.com/2072-6694/14/4/1070

Similar Items